Vladimir 12:05-12.20 Florida, US Can we improve prophylaxis and treatment of UTI by means of urine microbiome analysis? Mouraviev Riccardo Pisa, 12:20-12.35 MRI and prostate biopsy. Can a smartfinger with microchip replace it all? Bartoletti 12:35-12-50 Vitaly Smelov Lyon, France Is prostate cancer an infectious disease? New insight based on microbiome studies LUNCH 12:50-13:30 13:30-13:45 Bjørn Wullt Lund, Sweden The immune response in UTI 13:45-14:00 Reino Heikkilä Oslo, Norway Immune check point inhibitors and how it translates to treatment of prostate cancer Tamara 14:00-14:15 Moscow, Russia Antimicrobial resistance and the role of bacteriophage treatment in Russia Perpeanova P4 medicine a new paradigm in the prevention of UTI 14:15-14:30 Oleg Apolikhin Moscow, Russia (predictive, preventive, personalized, and participatory) Ekaterina Novosibirsk, 14:30-14.45 Occurrence, resistance and treatment of urogenital TB in Russia. Kulchavenja Russia Budapest, 14:45-15:00 Bela Koves Evidence based management of catheter-associated urinary tract infections Hungary Newcastle, UK and 15:00-15.15 Zafer Tandogdu Can we foresee antimicrobial resistance by of mathematical modelling? Oslo, Norway 15:15-15:25 Kurt Naber Munich,Germany Revival of old antibiotics to cope with antimicrobial resistance Florian 15:25-15:35 Giessen, Germany Novel antibiotics in the treatment of urinary tract infections Wagenlehner
12:05-12.20 Vladimir Mouraviev Florida, US Can we improve prophylaxis and treatment of UTI by means of urine microbiome analysis? 12:20-12.35 Riccardo Bartoletti Pisa, MRI and prostate biopsy. Can a smartfinger with microchip replace it all? 12:35-12-50 Vitaly Smelov Lyon, France Is prostate cancer an infectious disease? New insight based on microbiome studies 12:50-13:30 LUNCH 13:30-13:45 Bjørn Wullt Lund, Sweden The immune response in UTI 13:45-14:00 Reino Heikkilä Oslo, Norway Immune check point inhibitors and how it translates to treatment of prostate cancer 14:00-14:15 Tamara Perpeanova Moscow, Russia Antimicrobial resistance and the role of bacteriophage treatment in Russia 14:15-14:30 Oleg Apolikhin Moscow, Russia P4 medicine a new paradigm in the prevention of UTI (predictive, preventive, personalized, and participatory) 14:30-14.45 Ekaterina Kulchavenja Novosibirsk, Russia Occurrence, resistance and treatment of urogenital TB in Russia. 14:45-15:00 Bela Koves Budapest, Hungary Evidence based management of catheter-associated urinary tract infections 15:00-15.15 Zafer Tandogdu Newcastle, UK and Oslo, Norway Can we foresee antimicrobial resistance by of mathematical modelling? 15:15-15:25 Kurt Naber Munich,Germany Revival of old antibiotics to cope with antimicrobial resistance 15:25-15:35 Florian Wagenlehner Giessen, Germany Novel antibiotics in the treatment of urinary tract infections
Draft-program-Oslo-15-dec-2017.ed_.25.10.2017.docx